XML 101 R81.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 03, 2021
Oct. 28, 2021
Jun. 18, 2021
Jan. 31, 2021
Nov. 30, 2020
Jan. 31, 2020
Mar. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Nov. 23, 2020
Purchase agreements, description       the Company agreed to sell to the Purchasers a total of (i) $2,799,000 in the aggregate principal amount of 12.5% Original Issue Discount Senior Subordinated Secured Convertible Debentures (the “Debentures”), and (ii) 699,750 common stock purchase warrants (the “Warrants”), which represents 100% warrant coverage. The Company received a total of $2,488,000 in gross proceeds from the offerings, taking into account the 12.5% original issue discount, before deducting offering expenses and commissions, including the placement              
Issuance of shares                   175,422  
Principal amount (in Dollars)                     $ 250,000
Acquisition shares to be held in reserve       30,446              
Cash paid for acquisition (in Dollars)       $ 180,000       $ 2,304,528 $ 0    
Intangible assets acquired (in Dollars)             $ 16,000,000        
Stock Issued During Period, Value, Acquisitions (in Dollars)       $ 16,000,000              
Reverse stock split     1-for-2.5                
Accrued expenses               250,000      
Investor relations payment               $ 253,505      
Shares to be issued for an acquisition       205,867              
Exercise price (in Dollars per share)               $ 4.87   $ 2.24  
Original issue discount           1.50%          
Paycheck Protection Program Loan [Member]                      
Loan amount forgiven (in Dollars)       $ 24,750              
Stock Option [Member]                      
Options granted to purchase common stock (in Shares)   72,500                  
Exercise price (in Dollars per share)   $ 2.96                  
Vesting initial vesting date   October 28, 2022                  
Vesting period   over four years                  
Option term   five years                  
Preferred Stock Series D                      
Issuance of shares                   265,391  
Number of Series D shares cancelled                   8,755  
Number of warrants cancelled                   2,000  
Number of Series D shares converted to common                   53,078  
Series F Preferred Stock [Member]                      
Issuance of shares                   81,196  
Number of Series F preferred converted to common                   16,239  
Convertible Debt [Member]                      
Issuance of shares                   42,935  
Principal amount (in Dollars)         $ 283,984            
Conversion price                   $ 171,137  
Interest converted to shares (in Dollars)                   $ 602  
Convertible debt (in Dollars)         $ 250,000            
Original issue discount         12.50%            
Number of warrants       70,996              
2021 Equity Incentive Plan                      
Options granted to purchase common stock (in Shares) 32,500                    
Exercise price (in Dollars per share) $ 3.45                    
Vesting initial vesting date October 3, 2022                    
Vesting period four years                    
Term 5 years                    
Restricted common stock [Member]                      
Shares to be issued for an acquisition       1,441,065              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value (in Dollars per share)       $ 7.00              
2021 Equity Incentive Plan One                      
Options granted to purchase common stock (in Shares) 22,000                    
Exercise price (in Dollars per share) $ 3.45                    
Vesting initial vesting date January 3, 2022                    
Vesting period four years                    
Term 5 years                    
2021 Equity Incentive Plan Four                      
Options granted to purchase common stock (in Shares) 5,000                    
Exercise price (in Dollars per share) $ 3.45                    
Vesting initial vesting date October 3, 2022                    
Vesting period four years                    
Term 5 years                    
2021 Equity Incentive Plan Two                      
Options granted to purchase common stock (in Shares) 21,900                    
Exercise price (in Dollars per share) $ 3.45                    
Vesting initial vesting date January 3, 2022                    
Vesting period four years                    
Term 5 years                    
2021 Equity Incentive Plan Three                      
Options granted to purchase common stock (in Shares) 100,000                    
Exercise price (in Dollars per share) $ 3.45                    
Vesting initial vesting date October 3, 2021                    
Vesting period two years                    
Term 5 years